Imara, Inc.

Imara, Inc.

Imara, Inc.

Imara is dedicated to advancing new therapies to improve the lives of people living with sickle cell disease and other hemoglobinopathies.
Type
B2c
Founded
2015
Raised
$63M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$63,000,000
Venture capital (Series B) - 2019
OrbiMed
Team Size
1–10
Employees
Xconomy

Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO

Xconomy

Imara Reveals IPOs Plan as Sickle Cell Drug Advances in the Clinic